Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-21

Clinical Trial Update: ALPHA Sitagliptin Add on to Metformin (0431-103) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sitagliptin added to metformin for diabetes mellitus; results were posted in September 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucophage (metformin)
  • Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2010-09-21